OQS
IRWD icon

Occudo Quantitative Strategies’s Ironwood Pharmaceuticals IRWD Stock Holding History

Occudo Quantitative Strategies’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-173,082
Closed -$1.79M – 1163
2022
Q3 		$1.79M Buy
173,082
+128,128
+285% +$1.45M 0.14% 217
2022
Q2 		$518K Buy
+44,954
New +$530K 0.04% 608

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Occudo Quantitative Strategies's IRWD Position: Q4 2022 in Review

Occudo Quantitative Strategies sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2022, closing a stake of 173,082 shares — an estimated $1.79M sold.

Occudo Quantitative Strategies first reported a position in IRWD in Q2 2022 and held it in 2 quarters. The position peaked at $1.79M in Q3 2022. 250 funds tracked by Wall St. Rank hold IRWD as of Q4 2022.

  • Occudo Quantitative Strategies reported no remaining Ironwood Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 173,082 Ironwood Pharmaceuticals shares in Q4 2022, an estimated $1.79M.
  • Occudo Quantitative Strategies first reported a position in Ironwood Pharmaceuticals in Q2 2022 and held it in 2 quarters.
  • Occudo Quantitative Strategies's Ironwood Pharmaceuticals position peaked at $1.79M in Q3 2022.
  • 250 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.